Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes-Reference-Cited by-同舟云学术

Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes

Published:2016-04-22 Issue:10 Volume:25 Page:1186-1195
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Abdelmoneim Ahmed S.¹²,Eurich Dean T.²³,Senthilselvan Ambikaipakan³,Qiu Weiyu²,Simpson Scot H.¹²

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences; University of Alberta; Edmonton AB Canada

2. Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta; Edmonton AB Canada

3. School of Public Health; University of Alberta; Edmonton AB Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference51 articles.

1. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada;Canadian Diabetes Association Clinical Practice Guidelines Expert Committee;Can J Diabetes,2013

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results;Meinert;Diabetes,1970

4. Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies;Forst;Diabetes Vasc Dis Res,2013

5. Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis;Phung;Diabet Med,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety of sulfonylureas among U.S. nursing home residents;Journal of the American Geriatrics Society;2022-12-10

2. Comparison of Mitochondrial Adenosine Triphosphate–Sensitive Potassium Channel High- vs Low-Affinity Sulfonylureas and Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With Metformin;JAMA Network Open;2022-12-09

3. The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes;Journal of Personalized Medicine;2022-05-22

4. Sexual dimorphism in vascular ATP‐sensitive K + channel function supporting interstitial via convective and/or diffusive O 2 transport;The Journal of Physiology;2021-06-08

5. Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care;Diabetes/Metabolism Research and Reviews;2021-02-07